Dr. Agresta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1200 E Michigan Ave
Ste 145
Lansing, MI 48912Phone+1 517-364-5400Fax+1 517-364-5409
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2015 - 2018
UPMC Medical EducationResidency, Pediatrics, 2012 - 2015
Michigan State University College of Human MedicineClass of 2012
Certifications & Licensure
MI State Medical License 2019 - 2025
OH State Medical License 2015 - 2021
PA State Medical License 2012 - 2015- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Conquer Cancer Young Investigator Award 2020
Clinical Trials
- Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia Start of enrollment: 2018 Dec 27
Publications & Presentations
PubMed
- 87 citationsThe Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.Laura Agresta, Kasper Hoebe, Edith M. Janssen
Frontiers in Immunology. 2018-11-28 - 21 citationsPazopanib therapy for desmoid tumors in adolescent and young adult patientsLaura Agresta, Hee Kim, Brian Turpin, Rajaram Nagarajan, Alexandra Plemmons
Pediatric Blood & Cancer. 2018-06-01 - 31 citationsCD244 represents a new therapeutic target in head and neck squamous cell carcinoma.Laura Agresta, Maria A. Lehn, Kristin Lampe, Rachel Cantrell, Cassandra M. Hennies
Journal for Immunotherapy of Cancer. 2020-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
